Alcoholic Hepatitis Supportive Care Protocol

Alcoholic hepatitis is severe liver inflammation caused by heavy alcohol use. It can develop after years of heavy drinking or sometimes after binge drinking in people with existing liver disease. Symptoms include jaundice (yellow skin and eyes), abdominal pain, fever, nausea, and an enlarged, tender liver. Severe alcoholic hepatitis can be life-threatening, with mortality rates up to 50% at 30 days in the most serious cases.

CRITICAL: Alcoholic hepatitis is a serious medical condition requiring hospital care for moderate-to-severe cases. Treatment depends on severity (assessed by Maddrey's discriminant function or MELD score). Corticosteroids may be used for severe cases. COMPLETE ABSTINENCE from alcohol is essential - continuing to drink dramatically worsens outcomes. Nutrition support is critical as malnutrition is nearly universal. These supplements support liver recovery but don't replace medical treatment or the absolute need for alcohol cessation.

* Milk Thistle (Silymarin) is the most studied hepatoprotective herb. It stabilizes liver cell membranes, acts as an antioxidant, and may promote liver cell regeneration.

* N-Acetyl Cysteine (NAC) is a precursor to glutathione, the liver's primary antioxidant. A randomized trial showed NAC combined with prednisolone improved survival in severe alcoholic hepatitis compared to prednisolone alone.

* Resveratrol activates pathways (SIRT1, AMPK) that reduce liver inflammation and oxidative stress. It may help protect liver cells from alcohol-induced damage.

* Zinc deficiency is extremely common in alcoholic liver disease and contributes to liver dysfunction. Supplementation may improve liver function and reduce inflammation.

* SAMe is a methyl donor that becomes depleted in liver disease. It supports glutathione production and liver cell function.

* B Vitamins are commonly depleted in alcoholism. Thiamine is critical to prevent Wernicke's encephalopathy. B vitamins support liver metabolism and repair.

* Vitamin E provides antioxidant protection for liver cells under oxidative stress.

* Protein Supplementation addresses the protein-calorie malnutrition that is nearly universal in alcoholic hepatitis. Adequate protein is essential for liver regeneration.

Expected timeline: Mild alcoholic hepatitis may improve within weeks to months with abstinence and nutrition. Severe cases have high short-term mortality even with treatment. Long-term liver recovery depends on complete alcohol abstinence and may take 6-12 months or longer.

Clinical Perspective

Alcoholic hepatitis: acute onset of jaundice in setting of heavy alcohol use (typically >40g/day women, >60g/day men for >5 years). Clinical: hepatomegaly, jaundice, fever, leukocytosis, elevated AST/ALT ratio >2:1, elevated bilirubin. Severity: Maddrey Discriminant Function (MDF) ≥32 = severe (40% mortality). MELD score also prognostic. Complications: hepatic encephalopathy, ascites, hepatorenal syndrome, infection, GI bleeding.

CRITICAL: Hospitalize moderate-severe cases. Medical management: abstinence (essential), nutrition (1.5g/kg protein, 30-40 kcal/kg), thiamine. Severe (MDF≥32): prednisolone 40mg daily x 28 days if no infection/GI bleeding (Lille score at day 7 predicts response). Pentoxifylline alternative if steroids contraindicated (less effective). NAC as adjunct to steroids. Liver transplant for non-responders in select abstinent patients. Supplements are ADJUNCTIVE.

* Milk Thistle (Silymarin) (B-grade): Flavonolignans; antioxidant, anti-inflammatory, hepatoprotective. Cochrane review: may benefit alcoholic liver disease (PMID: 26461178). Systematic review supports use (PMID: 28246766). 420-600mg silymarin daily.

* NAC (B-grade): Glutathione precursor; antioxidant. Randomized trial: NAC + prednisolone improved 1-month survival vs prednisolone alone in severe AH (PMID: 21486085). Systematic review: hepatoprotective (PMID: 28578427). 600-1200mg BID.

* Resveratrol (B-grade): SIRT1/AMPK activation; anti-inflammatory. Review: hepatoprotective effects in ALD (PMID: 25684930). 150-500mg daily.

* Zinc (B-grade): Deficiency contributes to liver dysfunction, impaired immunity. Systematic review: supplementation may improve outcomes (PMID: 25715412). 30-50mg daily.

* SAMe (B-grade): Methyl donor; glutathione synthesis. Randomized trial: may improve survival in less severe liver disease (PMID: 12081215). 400-1600mg daily.

* B Vitamins (B-grade): Multiple deficiencies common. Review: thiamine essential, other B vitamins supportive (PMID: 15353705). Thiamine 100mg+, full B-complex.

* Vitamin E (C-grade): Antioxidant. Systematic review: may benefit liver disease (PMID: 24993607). 400-800 IU mixed tocopherols.

* Protein (B-grade): Malnutrition nearly universal. Guidelines: 1.2-1.5g/kg protein, 30-40 kcal/kg (PMID: 30236591). Enteral if needed; protein restriction NOT recommended except in encephalopathy.

Biomarker targets: Bilirubin (should decrease), AST/ALT (should improve), MDF, MELD score, Lille score at day 7 of steroids, INR/PT, albumin, creatinine.

Protocol notes: Complete alcohol abstinence is essential - any continued drinking worsens prognosis dramatically. Nutrition support critical - enteral feeding if needed. Screen for infections before steroids (chest x-ray, cultures, paracentesis if ascites). Steroids: prednisolone 40mg daily x 28 days; assess response at day 7 (Lille score). If non-responder (Lille >0.45), stop steroids. Pentoxifylline 400mg TID alternative (less effective than steroids). NAC IV x 5 days as adjunct to prednisolone. Treat complications: diuretics for ascites, lactulose for encephalopathy, PPI for bleeding prophylaxis. Monitor for hepatorenal syndrome (terlipressin + albumin). Early liver transplant evaluation for steroid non-responders - strict abstinence requirements. Long-term: refer for alcohol treatment, monitor for progression to cirrhosis, surveillance for HCC if cirrhotic.

View All Protocols